Objective. To determine the efficacy and safety of diacerhein, a potential new therapeutic agent with properties differing from those of existing nonsteroidal antiinflammatory drugs (NSAIDs), and of a combination of diacerhein and an NSAID (tenoxicam) in the treatment of osteoarthritis (OA) of the h
Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis
โ Scribed by Gerald N. Smith Jr.; Stephen L. Myers; Kenneth D. Brandt; Elizabeth A. Mickler; Marjorie E. Albrecht
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 182 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective To determine whether ascorbic acid might be of benefit for the treatment of spontaneous osteoarthritis (OA) when administered over a long period of time. ## Methods We investigated the effects of 8 months' exposure to low, medium, and high doses of ascorbic acid on the i
## Objective: It has been suggested that subchondral bone remodeling plays a role in the progression of osteoarthritis (oa). to test this hypothesis, we characterized the changes in the rat anterior cruciate ligament transection (aclt) model of oa and evaluated the effects of alendronate (aln), a p